Legal & General Group PLC Argenx Se Transaction History

Legal & General Group PLC

  • $431 Billion
  • Q3 2025

A detailed history of Legal & General Group PLC transactions in Argenx Se stock. As of the latest transaction made, Legal & General Group PLC holds 148,619 shares of ARGX stock, worth $135 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
148,619
Previous 125,809 18.13%
Holding current value
$135 Million
Previous $69.3 Million 58.07%
% of portfolio
0.03%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$538.64 - $768.0 $12.3 Million - $17.5 Million
22,810 Added 18.13%
148,619 $110 Million
Q2 2025

Aug 12, 2025
BUY
$532.27 - $656.65 $6.24 Million - $7.69 Million
11,715 Added 10.27%
125,809 $69.3 Million
Q1 2025

May 15, 2025
BUY
$571.0 - $671.75 $641,804 - $755,047
1,124 Added 0.99%
114,094 $67.5 Million
Q4 2024

Feb 13, 2025
BUY
$520.52 - $638.33 $1.4 Million - $1.72 Million
2,698 Added 2.45%
112,970 $69.5 Million
Q3 2024

Feb 28, 2025
SELL
$434.22 - $551.9 $1.48 Million - $1.89 Million
-3,417 Reduced 3.02%
109,553 $59.4 Million
Q3 2024

Nov 14, 2024
BUY
$434.22 - $551.9 $762,056 - $968,584
1,755 Added 1.62%
110,272 $59.8 Million
Q2 2024

May 29, 2025
BUY
$356.01 - $451.55 $9.51 Million - $12.1 Million
26,706 Added 32.93%
107,798 $46.4 Million
Q2 2024

Aug 14, 2024
BUY
$356.01 - $451.55 $9.56 Million - $12.1 Million
26,861 Added 32.9%
108,517 $46.7 Million
Q1 2024

May 29, 2025
SELL
$356.95 - $413.29 $11.8 Million - $13.6 Million
-33,002 Reduced 28.93%
81,092 $31.9 Million
Q1 2024

May 14, 2024
BUY
$356.95 - $413.29 $1.2 Million - $1.39 Million
3,354 Added 4.28%
81,656 $32.1 Million
Q4 2023

May 29, 2025
SELL
$338.91 - $506.01 $12.1 Million - $18.1 Million
-35,792 Reduced 31.37%
78,302 $29.8 Million
Q4 2023

Feb 15, 2024
BUY
$338.91 - $506.01 $4.72 Million - $7.04 Million
13,920 Added 21.62%
78,302 $29.8 Million
Q3 2023

Nov 14, 2023
BUY
$369.35 - $548.43 $1.11 Million - $1.64 Million
2,992 Added 4.87%
64,382 $31.7 Million
Q2 2023

Aug 14, 2023
BUY
$360.14 - $422.58 $3.68 Million - $4.32 Million
10,225 Added 19.98%
61,390 $23.9 Million
Q1 2023

May 15, 2023
BUY
$334.23 - $403.65 $594,260 - $717,689
1,778 Added 3.6%
51,165 $19.1 Million
Q4 2022

Feb 14, 2023
BUY
$342.17 - $402.31 $3.23 Million - $3.8 Million
9,453 Added 23.67%
49,387 $18.7 Million
Q3 2022

Nov 14, 2022
BUY
$343.2 - $395.75 $3.87 Million - $4.46 Million
11,278 Added 39.36%
39,934 $14.1 Million
Q2 2022

Aug 22, 2022
BUY
$269.58 - $378.88 $7.73 Million - $10.9 Million
28,656 New
28,656 $10.9 Million

Others Institutions Holding ARGX

# of Institutions
525
Shares Held
26M
Call Options Held
589K
Put Options Held
320K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $50.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email